PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: mfreedman@toh.ca.\', \'Merck Serono Ltd, Feltham, UK (an affiliate of Merck KGaA).\', \'Merck spol. s r.o., Bratislava, Slovakia (an affiliate of Merck KGaA).\', \'Merck Healthcare KGaA, Darmstadt, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-0348(21)00550-210.1016/j.msard.2021.103283
?:doi
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 34619487
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34619487>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34619487>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all